BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11172966)

  • 1. Antitumor effect of radioactive cisplatin (191Pt) on nude mice.
    Areberg J; Wennerberg J; Johnsson A; Norrgren K; Mattsson S
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):827-32. PubMed ID: 11172966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioenhancement by cisplatin with accelerated fractionated radiotherapy in a human tumour xenograft.
    Joschko MA; Webster LK; Bishop JF; Groves J; Yuen K; Olver IN; Narayan KN; Ball DL
    Cancer Chemother Pharmacol; 1997; 40(6):534-9. PubMed ID: 9332470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FK317, a novel substituted dihydrobenzoxazine, exhibits potent antitumor activity against human tumor xenografts in nude mice.
    Naoe Y; Inami M; Matsumoto S; Takagaki S; Fujiwara T; Yamazaki S; Kawamura I; Nishigaki F; Tsujimoto S; Manda T; Shimomura K
    Jpn J Cancer Res; 1998 Dec; 89(12):1306-17. PubMed ID: 10081492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of combined treatment with mild temperature hyperthermia and/or tirapazamine in the treatment of solid tumors: its independence of p53 status.
    Masunaga S; Ono K; Takahashi A; Ohnishi K; Ohnishi T; Suzuki M; Nagata K; Kinashi Y; Nagasawa H; Uto Y; Hori H
    Cancer Sci; 2003 Jan; 94(1):125-33. PubMed ID: 12708486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rebamipide does not interfere with the antitumor effect of radiotherapy or chemotherapy in human oral tumor-bearing nude mice.
    Shibamori M; Sato M; Uematsu N; Nakashima T; Sato A; Yamamura Y; Sasabe H; Umehara K; Sakurai K
    J Pharmacol Sci; 2015 Sep; 129(1):18-25. PubMed ID: 26320673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human glioblastoma and carcinoma xenograft tumors treated by combined radiation and imatinib (Gleevec).
    Oertel S; Krempien R; Lindel K; Zabel A; Milker-Zabel S; Bischof M; Lipson KE; Peschke P; Debus J; Abdollahi A; Huber PE
    Strahlenther Onkol; 2006 Jul; 182(7):400-7. PubMed ID: 16826359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antitumor effects of newly synthesized analogues of platinum (NK121) and bleomycin (NK313) in nude mice implanted human tumor].
    Yokoe H; Kanazawa H; Takahashi K; Sato K
    Gan To Kagaku Ryoho; 1991 Jan; 18(1):97-101. PubMed ID: 1702964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical efficacy and pharmacokinetics of AP5346, a novel diaminocyclohexane-platinum tumor-targeting drug delivery system.
    Rice JR; Gerberich JL; Nowotnik DP; Howell SB
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2248-54. PubMed ID: 16609041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metoclopramide enhances the effect of cisplatin on xenografted squamous cell carcinoma of the head and neck.
    Kjellén E; Wennerberg J; Pero R
    Br J Cancer; 1989 Feb; 59(2):247-50. PubMed ID: 2930689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amifostine as a protector against cisplatin-induced toxicity in nude mice.
    Johnsson A; Wennerberg J
    Acta Oncol; 1999; 38(2):247-53. PubMed ID: 10227448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatotoxicity and pharmacokinetics of cisplatin in combination therapy with a traditional Chinese medicine compound of Zengmian Yiliu granules in ICR mice and SKOV-3-bearing nude mice.
    Gong C; Qian L; Yang H; Ji LL; Wei H; Zhou WB; Qi C; Wang CH
    BMC Complement Altern Med; 2015 Aug; 15():283. PubMed ID: 26283082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of cisplatin and Lipoplatin™ in combined treatment with radiation of a colorectal tumor in nude mouse.
    Tippayamontri T; Kotb R; Paquette B; Sanche L
    Anticancer Res; 2013 Aug; 33(8):3005-14. PubMed ID: 23898053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo antineoplastic activity of a new platinum antineoplastic agent, (R)-(-)-1,1-cyclobutanedicarboxylate (2-aminomethylpyrrolidine)-platinum (II) (DWA2114R) on freshly separated human tumor cells and human tumor xenografts transplanted in nude mice--a comparison with cis-diammine-dichloroplatinum (CDDP).
    Nio Y; Imai S; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Tobe T
    Anticancer Res; 1991; 11(2):761-7. PubMed ID: 2064331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the potential of hexamethylenetetramine, compared with tirapazamine, as a combined agent with {gamma}-irradiation and cisplatin treatment in vivo.
    Masunaga S; Tano K; Watanabe M; Kashino G; Suzuki M; Kinashi Y; Ono K; Nakamura J
    Br J Radiol; 2009 May; 82(977):392-400. PubMed ID: 19153181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo efficacy of marimastat and chemoradiation in head and neck cancer xenografts.
    Skipper JB; McNally LR; Rosenthal EL; Wang W; Buchsbaum DJ
    ORL J Otorhinolaryngol Relat Spec; 2009; 71(1):1-5. PubMed ID: 18931526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.
    Komeda S; Takayama H; Suzuki T; Odani A; Yamori T; Chikuma M
    Metallomics; 2013 May; 5(5):461-8. PubMed ID: 23608770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective antitumor effects of the combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and cisplatin against esophageal squamous cell carcinoma.
    Kondo K; Yamasaki S; Inoue N; Sugie T; Teratani N; Kan T; Shimada Y
    Surg Today; 2006; 36(11):966-74. PubMed ID: 17072716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.
    Masunaga S; Uto Y; Nagasawa H; Hori H; Nagata K; Suzuki M; Kinashi Y; Ono K
    Anticancer Res; 2006; 26(2A):1261-70. PubMed ID: 16619533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Batimastat, a synthetic inhibitor of matrix metalloproteinases, potentiates the antitumor activity of cisplatin in ovarian carcinoma xenografts.
    Giavazzi R; Garofalo A; Ferri C; Lucchini V; Bone EA; Chiari S; Brown PD; Nicoletti MI; Taraboletti G
    Clin Cancer Res; 1998 Apr; 4(4):985-92. PubMed ID: 9563894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.